Skip to main content

Table 3 Receptor mechanisms of select neuropeptides

From: Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis

Neuropeptide

Receptor

Effectors & signaling molecules involved

Substance P/ Neurokinin A

neurokinin-1,2 & 3 receptors (NK-1,2 &3) (discussed and reviewed in [239] and [240]).

Gs and Gq [241,242,243].

↑ intracellular Ca2+, DAG, cAMP, IP3 [79, 239, 244,245,246].

CFTR has been implicated [100].

VIP

VPAC1, VPAC2 and PAC1 [30, 247].

Gs, Gi and Gq [248, 249].

↑ intracellular Ca2+, DAG, cAMP, IP3, [249].

CFTR has been implicated [132].

CGRP

CGRP-α subtype and CGRP-β subtype [31, 138, 250].

Gq and Gs [251].

↑ intracellular Ca2+, DAG, IP3, cAMP [251, 252].

NPY

Y-1, Y-2, Y-4 and Y-5 receptors [32, 34, 182].

Gi and Gq [182, 253].

↑ intracellular Ca2+, DAG, cAMP, IP3, [182, 253,254,255,256].

Bombesins (GRP-27; NMB)

NMB = subtype 1 receptor (BB1); GRP-27 = subtype 2 receptor (BB2); subtype-3 (BB3) = orphan [35].

Gi and Gq [35].

↑ intracellular Ca2+, DAG, cAMP, IP3 [35, 257].

Chromogranins (Secretoneurin)

Currently suspected, but not identified G-protein coupled receptor.

↑ intracellular Ca2+, cAMP [36].